Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 11.50%696.46M | 12.91%183.05M | 12.94%175.02M | 11.88%172.89M | 8.17%165.51M | 10.42%624.62M | 10.63%162.12M | 7.06%154.97M | 10.14%154.53M | 14.12%153.01M |
Operating revenue | 11.50%696.46M | 12.91%183.05M | 12.94%175.02M | 11.88%172.89M | 8.17%165.51M | 10.42%624.62M | 10.63%162.12M | 7.06%154.97M | 10.14%154.53M | 14.12%153.01M |
Cost of revenue | 6.21%341.98M | 7.40%86.7M | 6.34%85.96M | 6.64%86.06M | 4.45%83.26M | 4.09%321.97M | 0.48%80.73M | 3.77%80.83M | 4.24%80.7M | 8.20%79.71M |
Gross profit | 17.13%354.48M | 18.37%96.34M | 20.13%89.06M | 17.61%86.83M | 12.22%82.25M | 18.06%302.65M | 22.95%81.39M | 10.88%74.13M | 17.40%73.83M | 21.35%73.3M |
Operating expense | 3.02%389.12M | -0.52%95.51M | 5.03%98.73M | 4.61%99.56M | 3.01%95.31M | 8.94%377.71M | 5.25%96.01M | 6.69%94M | 10.65%95.18M | 13.12%92.52M |
Selling and administrative expenses | 4.18%228.89M | 0.64%57.2M | 5.25%57.05M | 5.71%59.02M | 5.27%55.62M | 10.75%219.71M | 8.88%56.84M | 7.17%54.21M | 12.19%55.83M | 14.26%52.84M |
-Selling and marketing expense | -3.26%105.95M | 2.49%27.22M | -2.16%25.56M | -3.37%27.73M | -9.59%25.45M | 1.21%109.52M | -6.84%26.55M | -6.59%26.12M | 8.40%28.7M | 11.39%28.14M |
-General and administrative expense | 11.58%122.94M | -0.97%29.99M | 12.15%31.5M | 15.32%31.28M | 22.21%30.18M | 22.21%110.19M | 27.80%30.28M | 24.19%28.08M | 16.50%27.13M | 17.72%24.69M |
Research and development costs | 4.30%143.24M | 4.23%35.72M | 6.83%36.9M | 4.88%35.76M | 1.27%34.86M | 5.56%137.33M | 0.68%34.27M | 4.36%34.54M | 7.11%34.1M | 10.58%34.43M |
Depreciation amortization depletion | -17.84%16.98M | -47.24%2.59M | -9.03%4.78M | -8.83%4.79M | -8.25%4.83M | 13.26%20.67M | -1.59%4.9M | 18.72%5.25M | 18.77%5.25M | 19.00%5.26M |
-Depreciation and amortization | -17.84%16.98M | -47.24%2.59M | -9.03%4.78M | -8.83%4.79M | -8.25%4.83M | 13.26%20.67M | -1.59%4.9M | 18.72%5.25M | 18.77%5.25M | 19.00%5.26M |
Operating profit | 53.86%-34.64M | 105.68%831K | 51.32%-9.67M | 40.34%-12.74M | 32.08%-13.06M | 16.96%-75.06M | 41.58%-14.62M | 6.49%-19.87M | 7.70%-21.35M | 10.14%-19.23M |
Net non-operating interest income expense | 161.18%11.4M | 75.81%3.51M | 222.75%3.26M | 419.39%2.73M | 128.00%1.9M | 432.27%4.37M | 146.24%2M | 537.66%1.01M | 147.91%526K | 204.52%832K |
Non-operating interest income | 61.83%16.34M | 38.29%4.68M | 98.32%4.62M | 82.82%3.85M | 40.11%3.19M | 88.33%10.1M | 37.52%3.39M | 63.94%2.33M | 273.58%2.11M | 148.74%2.28M |
Non-operating interest expense | -13.83%4.94M | -15.61%1.17M | 2.81%1.35M | -29.16%1.12M | -10.53%1.29M | -14.14%5.73M | -15.86%1.39M | -20.23%1.32M | -4.87%1.58M | -15.60%1.44M |
Other net income (expense) | -186.00%-7.63M | 29.21%-2.41M | 5.35%-3.13M | 58.34%-967K | -106.29%-1.13M | 161.69%8.87M | 54.47%-3.4M | 43.45%-3.31M | -253.81%-2.32M | 596,633.33%17.9M |
Special income (charges) | -186.00%-7.63M | 29.21%-2.41M | 5.35%-3.13M | 58.34%-967K | -106.29%-1.13M | 161.69%8.87M | 54.47%-3.4M | 43.45%-3.31M | -253.81%-2.32M | 596,633.33%17.9M |
-Less:Restructuring and merger&acquisition | -30.65%7.63M | -29.21%2.41M | -5.35%3.13M | -58.34%967K | -42.93%1.13M | -23.50%11M | -54.47%3.4M | -43.45%3.31M | 253.81%2.32M | 65,666.67%1.97M |
-Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---19.87M | --0 | ---- | ---- | ---19.87M |
Income before tax | 50.08%-30.86M | 112.08%1.94M | 56.96%-9.54M | 52.59%-10.97M | -2,367.47%-12.29M | 41.72%-61.82M | 49.43%-16.02M | 18.89%-22.16M | 6.99%-23.14M | 97.76%-498K |
Income tax | 115.50%7.68M | -13.94%1.77M | 124.65%2.26M | 336.12%2.09M | 8,538.89%1.56M | 22.49%3.56M | 180.14%2.06M | 114.50%1.01M | 40.88%479K | -98.68%18K |
Net income | 41.06%-38.54M | 100.91%164K | 49.08%-11.8M | 44.71%-13.06M | -2,582.75%-13.84M | 40.01%-65.38M | 44.22%-18.08M | 16.64%-23.17M | 6.34%-23.62M | 97.81%-516K |
Net income continuous Operations | 41.06%-38.54M | 100.91%164K | 49.08%-11.8M | 44.71%-13.06M | -2,582.75%-13.84M | 40.01%-65.38M | 44.22%-18.08M | 16.64%-23.17M | 6.34%-23.62M | 97.81%-516K |
Minority interest income | ||||||||||
Net income attributable to the parent company | 41.06%-38.54M | 100.91%164K | 49.08%-11.8M | 44.71%-13.06M | -2,582.75%-13.84M | 40.01%-65.38M | 44.22%-18.08M | 16.64%-23.17M | 6.34%-23.62M | 97.81%-516K |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 41.06%-38.54M | 100.91%164K | 49.08%-11.8M | 44.71%-13.06M | -2,582.75%-13.84M | 40.01%-65.38M | 44.22%-18.08M | 16.64%-23.17M | 6.34%-23.62M | 97.81%-516K |
Basic earnings per share | 42.86%-0.64 | 0 | 50.00%-0.2 | 46.34%-0.22 | -2,200.00%-0.23 | 41.05%-1.12 | 44.64%-0.31 | 16.67%-0.4 | 6.82%-0.41 | 97.56%-0.01 |
Diluted earnings per share | 42.86%-0.64 | 0 | 50.00%-0.2 | 46.34%-0.22 | -2,200.00%-0.23 | 41.05%-1.12 | 44.64%-0.31 | 16.67%-0.4 | 6.82%-0.41 | 97.56%-0.01 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |